Skip to main content

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Projects

RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2

IP: Pere Soler Palacín
Collaborators: Miriam Gonzalez Amores, Tamara Del Rio Higueras, Ariadna Martín Balcells, Amaia Latasa Arrazubi, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo, Maria Soraya Badia Ventura
Funding agency: EUROPEAN COMMISSION
Funding: 475000
Reference: RBDCOV_HE-HLTH-CORONA2021
Duration: 01/12/2021 - 31/05/2025

Related news

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

This appointment is an international recognition of VHIR's immunodeficiency research.

So far, 240 volunteers have been recruited within all the centres set to join adolescents’ clinical trial (named HH3) to test the efficacy, tolerability, and safety of the BIMERVAX® COVID-19 vaccine in adolescents aged 12 to 17.

Related professionals

González Sánchez Alejandra

González Sánchez Alejandra

Predoctoral researcher
Microbiology
Read more
Rodrigo Maluje Juri

Rodrigo Maluje Juri

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Marta Antonio Martín

Marta Antonio Martín

Predoctoral researcher
Cardiovascular Diseases
Read more
Daniel León González

Daniel León González

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.